文献速递免疫规划传染病防控与疫情报告

植物源蓝舌病嵌合病毒样颗粒疫苗在羊中诱导血清型特异性免疫

Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep.
PubMed 文献 · Vaccine · 2019-08-27

蓝舌病由蓝舌病毒(BTV)引起,经蠓传播, annual vaccination 是地方性流行区防控关键;现行多价减毒活疫苗(LAV)存在安全性顾虑。本研究在本氏烟草(Nicotiana benthamiana)中表达并组装同源BTV-8及嵌合BTV-3、BTV-4病毒样颗粒(VLP),经SDS-PAGE、透射电镜(TEM)和LC-MS/MS肽段测序确认。植物源嵌合BTV-3和BTV-4 VLP在羊中诱导与单价LAV对照相当的持久血清型特异性中和抗体,抗体水平至试验结束仍保持较高。

要点

  • 植物源嵌合BTV-3、BTV-4 VLP在羊中诱导与单价LAV相当的血清型特异性中和抗体
  • 抗体水平持续至试验结束仍保持较高
  • VLP不含非结构蛋白,具备区分免疫与感染(DIVA)潜力

核心结论

  • 植物源同源与嵌合蓝舌病VLP组合有望成为安全、有效的多价疫苗,并因缺乏非结构蛋白而具备DIVA能力。

研究设计与样本

  • 研究在N. benthamiana植物中表达并组装同源BTV-8及嵌合BTV-3、BTV-4 VLP,经SDS-PAGE、TEM和LC-MS/MS肽段测序确认,并在羊中评价免疫原性。

主要发现

  • 植物源嵌合BTV-3和BTV-4 VLP在羊中诱导持久血清型特异性中和抗体,水平与单价LAV对照相当,至试验结束仍保持较高。

关键数值与推荐

  • 以VP2为主要保护性免疫决定簇,用组装嵌合VLP中检测到的VP2肽段覆盖百分比和独特肽段数量指导选择最适嵌合组合。

临床怎么用

  • 提示植物源嵌合VLP可作为多价蓝舌病疫苗候选,并可能用于区分免疫与感染个体的监测场景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bluetongue (BT) is a hemorrhagic non-contagious, biting midge-transmitted disease of wild and domestic ruminants that is caused by bluetongue virus (BTV). Annual vaccination plays a pivotal role in BT disease control in endemic regions. Due to safety concerns of the current BTV multivalent live attenuated vaccine (LAV), a safe efficacious new generation subunit vaccine such as a plant-produced BT virus-like particle (VLP) vaccine is imperative. Previously, homogenous BTV serotype 8 (BTV-8) VLPs were successfully produced in Nicotiana benthamiana plants and provided protective immunity in sheep. In this study, combinations of BTV capsid proteins from more than one serotype were expressed and assembled to form chimaeric BTV-3 and BTV-4 VLPs in N. benthamiana plants. The assembled homogenous BTV-8, as well as chimaeric BTV-3 and chimaeric BTV-4 VLP serotypes, were confirmed by SDS-PAGE, Transmission Electron microscopy (TEM) and protein confirmation using liquid chromatography-mass spectrometry (LC-MS/MS) based peptide sequencing. As VP2 is the major determinant eliciting protective immunity, the percentage coverage and number of unique VP2 peptides detected in assembled chimaeric BT VLPs were used as a guide to assemble the most appropriate chimaeric combinations. Both plant-produced chimaeric BTV-3 and BTV-4 VLPs were able to induce long-lasting serotype-specific neutralizing antibodies equivalent to the monovalent LAV controls. Antibody levels remained high to the end of the trial. Combinations of homogenous and chimaeric BT VLPs have great potential as a safe, effective multivalent vaccine with the ability to distinguish between vaccinated and infected individuals (DIVA) due to the absence of non-structural proteins.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mokoena NB, Moetlhoa B, Rutkowska DA, et al. Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep. Vaccine. 2019. PMID: 31471154. doi:10.1016/j.vaccine.2019.08.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。